Cytokinetics (CYTK) FCF Margin (2010 - 2026)
Cytokinetics' FCF Margin came in at -262.25% for Q3 2026, up 5773.86 percentage points from -6036.11% a year earlier and up 311.16 percentage points from the prior quarter.
Cytokinetics (CYTK) FCF Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Cytokinetics reported FCF Margin of -519.53%, up 12.09 percentage points year-over-year; for FY2025, it came in at -607.48%.
- FCF Margin carries a five-year change of -603.70 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -5521.24% in FY2023 (-5192.60 pp), -328.64% in FY2022 (-56.88 pp) and -271.76% in FY2021 (-267.98 pp).
- The Q3 2026 figure represents the highest quarterly FCF Margin since Q2 2025.
- Year-over-year, FCF Margin increased in six of the last eight quarters, with an average year-over-year change of +10027.08 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2025 (a gain of 40455.55 percentage points), and the weakest in Q2 2024 (a drop of 26522.10 percentage points).
- Business Quant data shows CYTK's FCF Margin at -573.41% (Q2 2026), -782.38% (Q1 2026) and -835.23% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn | -262.25% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -262.25% |
| Jun 30, 2026 | -573.41% |
| Mar 31, 2026 | -782.38% |
| Dec 31, 2025 | -834.99% |
| Sep 30, 2025 | -6,038.27% |
| Jun 30, 2025 | -198.27% |
| Mar 31, 2025 | -8,694.17% |
| Dec 31, 2024 | -445.73% |
| Sep 30, 2024 | -22,073.65% |
| Jun 30, 2024 | -40,653.82% |
| Mar 31, 2024 | -15,509.82% |
| Dec 31, 2023 | -4,432.66% |
| Sep 30, 2023 | -25,509.26% |
| Jun 30, 2023 | -14,131.72% |
| Mar 31, 2023 | -2,659.61% |
| Dec 31, 2022 | -5,181.14% |
| Sep 30, 2022 | -3,593.28% |
| Jun 30, 2022 | -102.66% |
| Mar 31, 2022 | -2,417.51% |
| Dec 31, 2021 | -112.39% |
Cytokinetics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();